|European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I|
S Krege, J Beyer, R Souchon, P Albers, W Albrecht, F Algaba, M Bamberg, ...
European urology 53 (3), 478-496, 2008
|European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)|
HJ Schmoll, R Souchon, S Krege, P Albers, J Beyer, C Kollmannsberger, ...
Annals of oncology 15 (9), 1377-1399, 2004
|Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis|
C Bokemeyer, CR Nichols, JP Droz, HJ Schmoll, A Horwich, A Gerl, ...
Journal of Clinical Oncology 20 (7), 1864-1873, 2002
|High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.|
J Beyer, A Kramar, R Mandanas, W Linkesch, A Greinix, JP Droz, JL Pico, ...
Journal of clinical oncology 14 (10), 2638-2645, 1996
Journal of clinical oncology 13, 1328, 1995
|Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German …|
J Schetelig, C Thiede, M Bornhauser, R Schwerdtfeger, M Kiehl, J Beyer, ...
Journal of Clinical Oncology 21 (14), 2747-2753, 2003
|Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer|
J Beyer, P Albers, R Altena, J Aparicio, C Bokemeyer, J Busch, ...
Annals of oncology 24 (4), 878-888, 2013
|Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up|
J Oldenburg, SD Fosså, J Nuver, A Heidenreich, HJ Schmoll, ...
Annals of Oncology 24 (suppl_6), vi125-vi132, 2013
|Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.|
C Kollmannsberger, J Beyer, JP Droz, A Harstrick, JT Hartmann, P Biron, ...
Journal of Clinical Oncology 16 (10), 3386-3391, 1998
|Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial|
S Schwartz, G Behre, V Heinemann, H Wandt, E Schilling, M Arning, ...
Blood, The Journal of the American Society of Hematology 93 (11), 3654-3661, 1999
|Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database|
A Lorch, C Bascoul-Mollevi, A Kramar, L Einhorn, A Necchi, C Massard, ...
J Clin Oncol 29 (16), 2178-84, 2011
|Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors|
JT Hartmann, CR Nichols, JP Droz, A Horwich, A Gerl, SD Fossa, J Beyer, ...
Journal of the National Cancer Institute 92 (1), 54-61, 2000
|Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study …|
C Kollmannsberger, J Beyer, R Liersch, P Schöffski, B Metzner, O Rick, ...
Journal of clinical oncology 22 (1), 108-114, 2004
|Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with …|
O Rick, C Bokemeyer, J Beyer, JT Hartmann, N Schwella, D Kingreen, ...
Journal of clinical oncology 19 (1), 81-88, 2001
|Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest …|
HG Sayer, M Kröger, J Beyer, M Kiehl, SA Klein, K Schaefer-Eckart, ...
Bone marrow transplantation 31 (12), 1089-1095, 2003
|Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic …|
HJ Schmoll, C Kollmannsberger, B Metzner, JT Hartmann, N Schleucher, ...
Journal of clinical oncology 21 (22), 4083-4091, 2003
|Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome|
C Bokemeyer, JP Droz, A Horwich, A Gerl, SD Fossa, J Beyer, J Pont, ...
Cancer 91 (7), 1394-1401, 2001
|High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis|
J Beyer, S Stenning, A Gerl, S Fossa, W Siegert
Annals of oncology 13 (4), 599-605, 2002
|Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular …|
A Lorch, C Kollmannsberger, JT Hartmann, B Metzner, IGH Schmidt-Wolf, ...
Journal of clinical oncology 25 (19), 2778-2784, 2007
|Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR‐ligand mismatch after dose‐reduced conditioning and unrelated stem cell transplantation …|
N Kröger, B Shaw, S Iacobelli, T Zabelina, K Peggs, A Shimoni, A Nagler, ...
British journal of haematology 129 (5), 631-643, 2005